The promise of cognitive behavior therapy for
treatment of severe mental disorders: a review of
recent developments
The promise of cognitive behavior therapy for
treatment of severe mental disorders: a review of
recent developments
Cognitive behavior therapy (CBT), as exemplified by the model of psychotherapy developed and refined over the past 40 years by A.T. Beck and colleagues, is one of the treatments of first choice for ambulatory depressive and anxiety disorders. Over the past several decades, there have been vigorous efforts to adapt CBT for treatment of more severe mental disorders, including schizophrenia and the more chronic and/or treatment refractory mood disorders. These efforts have primarily studied CBT as an adjunctive therapy, i.e., in combination with pharmacotherapy. Given the several limitations of state-of-the-art pharmacotherapies for these severe mental disorders, demonstration of clinically meaningful additive effects for CBT would have important implications for improving public health. This paper reviews the key developments in this important area of therapeutics, providing a summary of the current state of the art and suggesting directions for future research
244-250
Thase, M.E.
56fb602d-818f-4d45-9967-90433505c9f4
Kingdon, D.G.
14cdc422-10b4-4b2d-88ec-24fde5f4329b
Turkington, D.
a1e362f5-4ff3-4d27-81cb-1c6ddbcbf5b9
October 2014
Thase, M.E.
56fb602d-818f-4d45-9967-90433505c9f4
Kingdon, D.G.
14cdc422-10b4-4b2d-88ec-24fde5f4329b
Turkington, D.
a1e362f5-4ff3-4d27-81cb-1c6ddbcbf5b9
Thase, M.E., Kingdon, D.G. and Turkington, D.
(2014)
The promise of cognitive behavior therapy for
treatment of severe mental disorders: a review of
recent developments.
World Psychiatry, 13, .
(doi:10.1002/wps.20149).
(PMID:25273290)
Abstract
Cognitive behavior therapy (CBT), as exemplified by the model of psychotherapy developed and refined over the past 40 years by A.T. Beck and colleagues, is one of the treatments of first choice for ambulatory depressive and anxiety disorders. Over the past several decades, there have been vigorous efforts to adapt CBT for treatment of more severe mental disorders, including schizophrenia and the more chronic and/or treatment refractory mood disorders. These efforts have primarily studied CBT as an adjunctive therapy, i.e., in combination with pharmacotherapy. Given the several limitations of state-of-the-art pharmacotherapies for these severe mental disorders, demonstration of clinically meaningful additive effects for CBT would have important implications for improving public health. This paper reviews the key developments in this important area of therapeutics, providing a summary of the current state of the art and suggesting directions for future research
Text
Thase_et_al-2014-World_Psychiatry.pdf
- Version of Record
Restricted to Repository staff only
Request a copy
More information
Published date: October 2014
Organisations:
Clinical & Experimental Sciences
Identifiers
Local EPrints ID: 376418
URI: http://eprints.soton.ac.uk/id/eprint/376418
ISSN: 2051-5545
PURE UUID: 2d99871d-f319-4395-94cd-a05cc84de219
Catalogue record
Date deposited: 27 Apr 2015 12:35
Last modified: 14 Mar 2024 19:42
Export record
Altmetrics
Contributors
Author:
M.E. Thase
Author:
D.G. Kingdon
Author:
D. Turkington
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics